In several different cancer cell models, the DNA2 inhibitor suppressed proliferation of cancer cells with oncogene-induced replication stress (Kumar et al., 2017), suggesting a potential avenue of further exploration for cancer therapy. This evidence concerns the gene DNA2 and cancer.